Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs

Página do item simplificado
dc.creatorGeorgiev, Tsvetoslav
dc.date.accessioned2020-04-07T19:07:18Z
dc.date.available2020-04-07T19:07:18Z
dc.date.issued2020
dc.description.abstractIndisponível.pt_BR
dc.description.resumoIndisponível.pt_BR
dc.identifier.citationGEORGIEV, T. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs. Rheumatology International, [S.l.], v. 40, p. 825-826, 2020.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/39870
dc.identifier.urihttps://link.springer.com/article/10.1007/s00296-020-04570-zpt_BR
dc.languageen_USpt_BR
dc.publisherSpringerpt_BR
dc.rightsopenAccesspt_BR
dc.sourceRheumatology Internationalpt_BR
dc.subjectCOVID 19pt_BR
dc.subjectCOVID 19 - Drugspt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.titleCoronavirus disease 2019 (COVID-19) and anti-rheumatic drugspt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição:
Baixar

Coleções

FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)